Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
MSD Pharmaceuticals Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Group 1 PAH patient 18 years and older at the time of diagnosis of PAH with or without definitive diagnostic methods 2. Patient with WHO FC: II, III or IV 3. Patient with availability of minimum 3 months health record data post index date
Exclusion criteria
Exclusion criteria: 1.Patient with missing mandatory variables 2. Patient diagnosed with other than Group 1 PAH, as per clinical classification. 3. All patients who were part of any clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1a. PAH specific drug regimen: Proportion of patients with different classes of PAH specific treatment 1b. Switching of treatment: Proportion of patients reporting change in different classes of PAH specific treatment 1c. Add on therapy: Proportion of patients requiring add on therapyTimepoint: 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 2a. Diagnostic method: Proportion of patients diagnosed using RHC/non-RHC method 2b. Comorbidity: Proportion of patients with comorbid conditionTimepoint: 24 months | — |
Countries
India
Contacts
Public ContactDr Minal Patil
MSD Pharmaceuticals Pvt Ltd
Outcome results
None listed